Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

METABOLISM OF CHLORPHENIRAMINE MALEATE IN MAN

E. A. Peets, M. Jackson and S. Symchowicz
Journal of Pharmacology and Experimental Therapeutics February 1972, 180 (2) 464-474;
E. A. Peets
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Jackson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Symchowicz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The pharmacokinetics and metabolism of 3H-chlorpheniramine maleate have been studied in man. After a p.o. dose (12 mg), 3H appeared rapidly in plasma and at two hours was equivalent to 32.48 mµg of chlorpheniramine per ml; radioactivity persisted in plasma through 48 hours. At five minutes after an i.v. dose (4 mg), 3H in plasma was equivalent to 20.88 mµg of drug per ml and 3H again persisted in plasma. This persistence of plasma 3H was most probably due to tissue deposition of 3H-drug (or metabolites), directly indicated by its large volume of distribution, 250% of body weight. The drug was 72% bound to plasma protein. Unchanged drug as well as its metabolites were present in plasma, however, and in contrast to the persistent levels of 3H in plasma, the levels of 3H-chlorpheniramine declined steadily, although slowly, after the i.v. dose and after the two-hour peak after administration p.o. The plasma half-life of a p.o. dose was 12 to 15 hours and that of an i.v. dose, 28 hours. Excretion of the 3H-drug was slow and only one-third of a p.o. or i.v. dose was recovered from the excreta during 48 hours after administration. The p.o. dose was completely absorbed, however, and only small amounts of the 3H-drug were excreted into feces after its administration. Fecal excretion of 3H of an i.v. dose indicated that 3H-chlorpheniramine underwent an enterohepatic circulation. Chlorpheniramine was extensively metabolized and excreted in the urine as mono- and didesmethyl chlorpheniramine, two unidentified metabolites and small amounts of chlorpheniramine. The greatest portion of the drug was excreted as an unidentified polar metabolite(s).

Footnotes

    • Received May 13, 1971.
    • Accepted October 21, 1971.
  • © 1972 by The Williams & Wilkins Co.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 180, Issue 2
1 Feb 1972
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
METABOLISM OF CHLORPHENIRAMINE MALEATE IN MAN
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

METABOLISM OF CHLORPHENIRAMINE MALEATE IN MAN

E. A. Peets, M. Jackson and S. Symchowicz
Journal of Pharmacology and Experimental Therapeutics February 1, 1972, 180 (2) 464-474;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

METABOLISM OF CHLORPHENIRAMINE MALEATE IN MAN

E. A. Peets, M. Jackson and S. Symchowicz
Journal of Pharmacology and Experimental Therapeutics February 1, 1972, 180 (2) 464-474;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

Article

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Analysis of Expression of cGMP-Dependent Protein Kinase in Rabbit Heart Cells
Show more Article

Articles

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Analysis of Expression of cGMP-Dependent Protein Kinase in Rabbit Heart Cells
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics